Vaxcyte, Inc. (PCVX)
56.48
+0.43
(+0.77%)
USD |
NASDAQ |
Oct 02, 16:00
56.49
+0.01
(+0.02%)
After-Hours: 20:00
Vaxcyte Price : 56.48 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 56.76 | 57.00 | 55.84 | 56.48 | 2.400M |
| Oct 01, 2026 | 56.73 | 57.17 | 56.00 | 56.05 | 1.166M |
| Sep 30, 2026 | 56.69 | 57.50 | 56.13 | 56.90 | 1.509M |
| Sep 29, 2026 | 57.96 | 58.98 | 55.91 | 56.69 | 1.494M |
| Sep 28, 2026 | 56.50 | 58.82 | 55.75 | 58.27 | 1.849M |
| Sep 25, 2026 | 57.22 | 57.50 | 55.92 | 56.21 | 947291.0 |
| Sep 24, 2026 | 55.86 | 57.59 | 55.08 | 56.90 | 1.852M |
| Sep 23, 2026 | 59.02 | 59.10 | 55.09 | 56.50 | 1.650M |
| Sep 22, 2026 | 59.45 | 59.96 | 58.78 | 59.02 | 1.283M |
| Sep 21, 2026 | 59.00 | 60.54 | 57.62 | 58.92 | 1.124M |
| Sep 18, 2026 | 60.37 | 60.37 | 57.01 | 58.13 | 2.717M |
| Sep 17, 2026 | 60.22 | 61.50 | 59.31 | 60.37 | 1.309M |
| Sep 16, 2026 | 59.25 | 60.13 | 58.40 | 58.77 | 1.249M |
| Sep 15, 2026 | 59.70 | 59.75 | 58.18 | 59.21 | 1.888M |
| Sep 14, 2026 | 60.04 | 60.85 | 59.08 | 59.54 | 1.428M |
| Sep 11, 2026 | 60.07 | 60.20 | 58.21 | 59.47 | 1.683M |
| Sep 10, 2026 | 59.19 | 60.13 | 58.56 | 58.90 | 1.161M |
| Sep 09, 2026 | 59.99 | 60.33 | 59.04 | 59.51 | 1.195M |
| Sep 08, 2026 | 60.25 | 61.03 | 59.22 | 60.36 | 1.024M |
| Sep 04, 2026 | 59.73 | 61.78 | 59.64 | 61.16 | 986707.0 |
| Sep 03, 2026 | 61.73 | 62.14 | 59.85 | 61.17 | 736473.0 |
| Sep 02, 2026 | 61.63 | 62.90 | 60.82 | 61.58 | 1.021M |
| Sep 01, 2026 | 60.29 | 62.14 | 60.06 | 60.81 | 1.441M |
| Aug 31, 2026 | 59.10 | 61.61 | 58.51 | 60.74 | 1.749M |
| Aug 28, 2026 | 61.06 | 62.38 | 59.48 | 59.84 | 760160.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 190.01 |
| Arrowhead Pharmaceuticals, Inc. | 64.19 |
| Oncolytics Biotech, Inc. | 0.631 |
| Sangamo Therapeutics, Inc. | 0.1475 |
| Sarepta Therapeutics, Inc. | 17.50 |
Price Related Metrics
| PEG Ratio | -0.0873 |
| Price to Book Value | 2.965 |
| Earnings Yield | -13.65% |
| Market Cap | 8.178B |
| PEGY Ratio | -0.0873 |